--2024/H1861.300K / ----
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Louisiana-Pacific
LPX
AU Stock MarketDetailed Quotes
NUZ Neurizon Therapeutics Ltd
- 0.135
- -0.005-3.57%
20min DelayNot Open May 12 15:50 AET
66.46MMarket Cap-6.43P/E (Static)
0.145High0.135Low273.31KVolume0.145Open0.140Pre Close38.68KTurnover0.24552wk High0.08%Turnover Ratio492.31MShares0.09652wk Low-0.021EPS TTM47.44MFloat Cap0.245Historical HighLossP/E (Static)351.37MShs Float0.096Historical Low-0.021EPS LYR7.14%Amplitude--Dividend TTM5.63P/B1Lot Size--Div YieldTTM
Neurizon Therapeutics Ltd Key Stats
Neurizon Therapeutics Ltd Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Neurizon Therapeutics Ltd Earnings Reports
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting